Romaldas Mačiulaitis, MD, PharmD Lithuanian University of Health Sciences, EMA/CAT Member

Romaldas Mačiulaitis completed his MD and PharmD studies more than 20 years ago and after PhD studies in clinical pharmacology, became involved in drug regulatory and scientific appraisals at the national (Lithuanian) and international (European) levels, in particular as a national scientific expert for several of the European Medicines Agency, EMA Scientific Committees - Committee for Human Medicinal Products, CHMP (for last 12 years), the Committee for Advanced Therapies, CAT (since the very beginning of this Committee - for last 8 years), and Scientific Advice Working Party (for last 2 years).

In 2009, he initiated the new experimental pharmacology research direction in his University in Kaunas - on Regenerative Pharmacology, applying cell preparations with the focus on PK/PD of cell therapies in renal and cartilage injuries. He has published more than 40 papers in reputable journals.